ENDPOINTS

Patient dies in Rocket gene therapy trial; Lilly’s $1B deal for a non-opioid pain biotech; A new dawn for psychedelics?; and more

Welcome back to Endpoints Weekly! The last week in May brought a lot of news, and it isn’t over yet. We’ve got reporters on the ground at the ASCO meeting in Chicago this weekend, so ...

May 31, 2025 - 11:24
 0
Patient dies in Rocket gene therapy trial; Lilly’s $1B deal for a non-opioid pain biotech; A new dawn for psychedelics?; and more
Welcome back to Endpoints Weekly! The last week in May brought a lot of news, and it isn’t over yet. We’ve got reporters on the ground at the ASCO meeting in Chicago this weekend, so ...
Read More

Tags:

Previous Article

Infamous 'neutron lifetime puzzle' may finally have a solution — but it involves...

Next Article

Enamel proteins from Paranthropus robustus teeth reveal biological sex and genet...

Related Posts

Pharmacy Empower allegedly used low-quality ingredients, skirted rules

Pharmacy Empower allegedly used low-quality ingredients...

May 15, 2025  0

What we know about ‘most favored nation’; GSK’s $1.2B MASH deal; Bayer details staff cuts; and more

What we know about ‘most favored nation’; GSK’s $1.2B M...

May 17, 2025  0

SK, Carlyle bolster bluebird bio bid; Therini Bio raises $39M

SK, Carlyle bolster bluebird bio bid; Therini Bio raise...

May 14, 2025  0